11
Jun
2020
Oblique Therapeutics AB has identified a potentially important epitope for generation of SARS-CoV-2 antibodies
Read more with our English Press Release:
Oblique Therapeutics > News > Company updates > Oblique Therapeutics AB has identified a potentially important epitope for generation of SARS-CoV-2 antibodies
